Building @numenbio with @_tom_dot_com to engineer a future without cancer deaths. Find out more below in an interview with our partners at @TQVentures!
A cancer test that runs inside a cup. Taken at home, with results sent to your doctor in 30 minutes. Built in a San Francisco lab by a team that started in a shipping container.
What it actually takes to build it:
“If we spend ten, 20, 30, 40 years working on this, that’s okay. The outcome will be worth it.”
@luca_springer, co-founder and CEO of @numenbio
Timestamps:
00:00 Welcome to Numen
00:56 Why catch cancer early
01:24 The first lab was a shipping container
02:28 What the data unlocks next
03:23 National team MVP to founder
04:13 Why bladder cancer first
05:33 The candle prototype
06:25 Meet Atlas, a lab in a cup
06:55 NASA engineers under one roof
07:32 The Viennese café
08:08 Pipette pong
08:46 From the dungeon to Golden Gate Park
09:28 The only milestone that matters
09:59 40 years on one problem
A cancer test that runs inside a cup. Taken at home, with results sent to your doctor in 30 minutes. Built in a San Francisco lab by a team that started in a shipping container.
What it actually takes to build it:
“If we spend ten, 20, 30, 40 years working on this, that’s okay. The outcome will be worth it.”
@luca_springer, co-founder and CEO of @numenbio
Timestamps:
00:00 Welcome to Numen
00:56 Why catch cancer early
01:24 The first lab was a shipping container
02:28 What the data unlocks next
03:23 National team MVP to founder
04:13 Why bladder cancer first
05:33 The candle prototype
06:25 Meet Atlas, a lab in a cup
06:55 NASA engineers under one roof
07:32 The Viennese café
08:08 Pipette pong
08:46 From the dungeon to Golden Gate Park
09:28 The only milestone that matters
09:59 40 years on one problem
We’ve been building quietly at @numenbio for the past few years. Tomorrow we’re sharing more for the first time, in a conversation with Schuster at @TQVentures.
Here’s a teaser; full interview tomorrow.
A startup doesn't have to be your life's work, but if it is, you become much harder to defeat. You play the long game and you outlast everyone. Because practically everyone else is an opportunist by comparison.
The Iso team has cooked something incredible: our new technical report unveils the latest results from our drug design engine, the IsoDDE, progressing far beyond AlphaFold 3. This breaks new ground compared to AF and other similar methods by a significant degree across all key benchmarks. 1/7
New science from Richard Zhou... When our blood cells lyse, they release haemoglobin, which is dangerous to our body. We detoxify this by binding it to a serum protein, haptoglobin and taking it up into macrophages, using the receptor CD163. Richard showed how CD163 works!
Cleancard (YC S23) combines synthetic biology and artificial intelligence to make at-home cancer screens that are as easy to use as a pregnancy test.
https://t.co/IV8QPuAbN3
Congrats on the launch, @_tom_dot_com and @luca_springer!
Cleancard (YC S23) combines synthetic biology and artificial intelligence to make at-home cancer screens that are as easy to use as a pregnancy test.
https://t.co/IV8QPuAbN3
Congrats on the launch, @_tom_dot_com and @luca_springer!
So happy my main PhD work is now out @Cancer_Cell. We found biomarkers (TMB+TMC) that identify which patients with inoperable esophageal cancer (and some forms of gastric cancer) are likely to benefit most from immunotherapy. Tweetorial below, pls share! https://t.co/F9f9QvMkBN
To solve the world’s hardest problems, we must strengthen democratic values, collaboration, and security as technology reshapes our world.
Today, we’re excited to announce the 2023 cohort of International Strategy Forum Fellows.
Read more:
https://t.co/0HF0D2a4Zv
1/We think the biggest company in the world will be a consumer health tech company. Four of the top five biggest companies in the world are consumer companies, and healthcare is one of the nation’s biggest industries. @daisydwolf@a16z@a16zBioHealth
https://t.co/RoHjqgucda